ÌÇÐÄÆƽâ°æ

Forecasted CAGR for pharmaceutical specialty excipient demand due to COVID-19 worldwide in 2019-2024*

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

May 2020

Region

Worldwide

Survey time period

as of May 2020

Supplementary notes

* For oral solid dosage forms (OSDF).

Citation formats

Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

Published by A. Minhas, May 20, 2020
It is estimated that from 2019 to 2024 the CAGR of the demand for pharmaceutical specialy excipients will be approximately *** percent in a best case scenario. The growth between 2019 and 2020 will probably be around **** percent due to the impact of the coronavirus.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Ventilators and testing

7

Business impact

4

Medtech - before the pandemic

5

Opinions on COVID-19 vaccines

6

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in GermanyDoctors in GermanyPharmaceutical industry in AustraliaHospitals in GermanyPharmaceutical industry in Southeast Asia
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.